Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Author:

Ridker Paul M1,Everett Brendan M.1,Thuren Tom1,MacFadyen Jean G.1,Chang William H.1,Ballantyne Christie1,Fonseca Francisco1,Nicolau Jose1,Koenig Wolfgang1,Anker Stefan D.1,Kastelein John J.P.1,Cornel Jan H.1,Pais Prem1,Pella Daniel1,Genest Jacques1,Cifkova Renata1,Lorenzatti Alberto1,Forster Tamas1,Kobalava Zhanna1,Vida-Simiti Luminita1,Flather Marcus1,Shimokawa Hiroaki1,Ogawa Hisao1,Dellborg Mikael1,Rossi Paulo R.F.1,Troquay Roland P.T.1,Libby Peter1,Glynn Robert J.1

Affiliation:

1. From the Center for Cardiovascular Disease Prevention (P.M.R., B.M.E., J.G.M., R.J.G.) and the Cardiovascular Division (P.M.R., B.M.E., P.L.), Brigham and Women’s Hospital, Harvard Medical School, Boston; Novartis, East Hanover, NJ, and Basel, Switzerland (T.T., W.H.C.); Baylor College of Medicine, Houston (C.B.); Federal University of São Paulo (F.F.) and the Heart Institute (InCor), University of São Paulo Medical School (J.N.), São Paulo, and Faculdade Evangelica de Medicina do Parana, Curitiba (P.R.F...

Publisher

Massachusetts Medical Society

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3